Vmn1r135 Activators

Vomeronasal 1 receptor 135 activators are a class of chemical compounds that interact with and enhance the activity of Vmn1r135. These activators include ketones such as 2-heptanone and cyclotetradecanone, which bind directly to the ligand-binding site of Vmn1r135, inducing a structural change that leads to the activation of the associated G-protein. This activation catalyzes a signaling cascade that results in the enhancement of intracellular calcium signaling, a crucial step in the functional activation of Vmn1r135. Biogenic amines like putrescine and cadaverine also serve as direct activators by binding to Vmn1r135, which in turn stimulates the G-protein-mediated signaling pathway leading to the release of intracellular calcium stores, further enhancing the receptor's signaling capabilities.

Additionally, compounds such as isoamyl acetate andbeta-ionone act as ligands that facilitate the interaction with the olfactory receptors within the vomeronasal system, including Vmn1r135. The binding of these ligands to Vmn1r135 triggers a G-protein-mediated signal transduction pathway that leads to an increase in intracellular calcium levels, a key step in the activation of the receptor's signaling function. Piperine enhances the availability and binding efficiency of these ligands to Vmn1r135, thereby indirectly enhancing the receptor's functional activity. Moreover, sulfated steroids, androstenone, androstadienone, and estratetraenol, which are part of the steroid family, have been found to act as agonists to Vmn1r135. Their binding to the receptor site initiates a conformational change, leading to G-protein activation and a subsequent rise in intracellular calcium levels, culminating in the receptor's functional enhancement. Bourgeonal, a synthetic fragrance compound, also binds to Vmn1r135, eliciting a similar G-protein-coupled response that facilitates the receptor's activation.